Scientific Posters & Practice Pearl Posters
 
 

Monday, September 11

10:00-10:40 am
IMAGING

201   The Use of Microperimetry Analysis to Reduce the Risk of Laser-induced Damage to Visual Functioning in Patients with CSME and Extra-foveal Fixation Fareed Ali, MD, FRCS(C)
202   Spectral OCT in Follow–up of patients after MH Surgery Slawomir Cisiecki
203   OCT findings in CSC and RRD Sun Young Lee, MD
204   Ultrasound Biomicroscopy of the Sclerotomy Sites following Pars Plana Vitrectomy for Diabetic Eye Disease Tamer Macky, MD
205   OCT and Lenticular Opacification Keshav Narain, MD
206   Fundus Autofluorescence in CSC Seung-Young Yu, MD, PhD
207   Multifocal Electroretinogram Functional Aspects in Different Phenotypes of ARMD Alain Zourdani
 
SURGICAL DEVICES & INSTRUMENTATION

208   Effect of Volume used in Sub-Tenon's Anesthesia on Efficacy and Intraocular pressure in Vitreoretinal surgery Dong Heun Nam, MD
209   Posterior Segment Surgeries with Modified (Two Port) Multiport Illumination System Hamdi Er, MD
210   A new step in Sutureless Vitrectomy Jean-Pierre Hubschman
211   Surgical approach to the macula: a mathematical model Sal Rassam
212   Tired, Using the Wrong Hand: Lessons learned from the EYESI Virtual Reality Surgical Simulator, a Potential Tool in Resident/Fellow Surgical Teaching Feisal A Adatia, MD
213   Retrospective Review of 25 Gauge Vitrectomy Surgery David S. Dyer, MD
214   The Iatrogenic Price of Some Tips & Tricks Vincenzo Ferrara, MD
215   25g Sutureless Surgery and Silicone Oil Injection Athanasios Nikolakopoulos, MD
216   Secondary Glaucoma after Pars Plana Vitrectomy Lidmila Prochazkova, MD
217   Decompression Retinopathy Post-25-Gauge Transconjunctival Sutureless Vitrectomy Flavio A Rezende, MD, PhD
218   Sutureless 25G and 23G Vitrectomy under Topical Anaesthesia Ioannis P Theocharis, MD
219   Outcomes of 25-gauge Transconjunctival Sutureless Vitrectomy Nur Acar, MD
220   Outcomes of 76 Consecutive Cases of 23-Gauge Sutureless Transconjunctival Surgery for Posterior Segment Disease Howard F. Fine, MD
221   Management of Dropped nucleus and coexisting retinal pathology: Our experience Vineeth Balakri Kumar, MD
222   Combined Pars Plana Vitrectomy and Primary Scleral Fixated Intraocular Lens Angela Loo, MD
223   Pars plana vitrectomy with binocular indirect ophthalmoscope Daniel Ochoa-Contreras, MD
224   Ophthalmic Microendoscope - assisted Vitreoretinal Surgery in Various Etiologies Emin Ozmert, MD
225   Subretinal Schwann cell injections preserve plexiform synapses and retinal function in RCS rats Isabel Pinilla, MD
226   A Masking Method to Create "Custom" Laser Spots for use in PDT Edwin H. Ryan, MD
227   Method of Safe Vitrectomy Technique Andriy Sergienko, MD
 
PHARMACOLOGY
 
228   Safety of an Intravitreal Injection of Bevacizumab (Avastin ®): Results of a Multicenter Trial Lihteh Wu, MD
229   Multifocal Electrophysiologic Findings after Intravitreal Bevacizumab (Avastin) Treatment Myriam Lucia Hernandez-Rojas, MD
230   Autonomic Autoregulation Preserves Choroidal Blood Flow In Response to Intravenous Phenylephrine Challenge Vicente A Diaz, MD
231   Ethambutol optic neuropathy with favorable visual outcome Paul B. Griggs, MD
232   Long-Term Retinal Toxicity of Intravitreal Commercially-Available Preserved Triamcinolone Acetonide (Kenalog) in Rabbit Eyes Eric R. Holz, MD
233   Neuroprotective Effects of Sustained-Release Intravitreal Fluocinolone Acetonide in RCS Rats Raymond Iezzi, MD
234   Secondary Glaucoma after Intravitreal Triamcinolone Acetate Injection Ferenc Kuhn, MD, PhD
235   Retinal Toxicity to Triamcinolone Acetonide's Vehicle: An Electrophysiology and Electromicroscopy Study Tamer Macky, MD
236   IVT Acetonide in silicone filled eye to prevent presilicone fibrosis and inferior proliferative vitreoretinopathy Morteza Mehdizadeh, MD
237   Reliable and Reproducible Dosage Delivery of Triamcinolone Acetonide Prepared for Intravitreal Injection Daniel B. Roth, MD
238   Preclinical Safety Evaluation of Intravitreal Injection of Full-Length Humanized Rhumab Vascular Endothelial Growth Factor Antibody in Rabbit Eyes Ubeyt INAN Umit, MD
 
SOCIOECONOMICS
 
239   Criteria for Selecting Retina Fellows by Retina Fellowship Directors in the United States Ron A. Adelman, MD, MPH
240   Economic Analyses of Therapeutics for MD: A cross-national systematic review Amalia M Issa, PhD
241   "What's Old at the Movies" William S. Tasman